A Study that Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-005243-28

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To collect follow-up safety data from patients in completed abiraterone acetate studies. Consideration will be given to extending the duration of the study following review of the safety data at 3 years.


Critère d'inclusion

  • Metastatic Castration-Resistant Prostate Cancer (PCR)